Core Insights - The financing market in November 2025 is characterized by a shift from a focus on traffic to a deeper valuation of the beauty industry, indicating a significant transformation in capital assessment logic [4][5] - The trend shows that capital is increasingly cautious, with a notable concentration of funds towards leading foreign brands, reflecting a "Matthew Effect" in the industry [5][6] Financing Overview - In November 2025, there were 9 financing events exceeding 200 million yuan, but the total financing amount of over 300 million yuan indicates a cooling market compared to previous years [4][5] - The number of financing cases has decreased significantly from 14 in November 2021 to just 5 in November 2024, highlighting a trend of capital retreat from domestic beauty brands [5][6] Upstream Sector Dynamics - The upstream sector remains hot, with 7 out of 9 financing cases involving upstream companies, particularly in synthetic biology, which aligns with the industry's trend towards sustainable and efficient production [6][7] - Notable financing events include nearly 100 million yuan raised by Xiushi Biopharmaceuticals and several million yuan investments in Huaron Biotech, both focusing on synthetic biology [9][11] Brand Investment Trends - Significant investments in brand segments include Estée Lauder's minority stake in the Mexican high-end perfume brand Xinú and L'Oréal's strategic investment in the Chinese pure skincare brand "LAN" [15][19] - The global fragrance market is projected to grow significantly, with estimates reaching between 57 billion to 61 billion USD in 2024, indicating strong potential for investment in this sector [17][19] Future Outlook - The changes in the beauty financing market reflect the natural evolution of the industry, with a focus on technological innovation and niche market development expected to drive future growth [20]

Core Viewpoint - The company has established an advanced technology platform and product library in the field of non-natural amino acids, with a commitment to continuous technological innovation to support global customers in drug development [1] Summary by Categories Technology and Product Development - The company has developed tens of thousands of non-natural amino acids, with over 10,000 catalog products available [1] - More than 1,300 products are in stock, and over 100 products have kilogram-level production experience [1] - The company can supply over 20 products at the hundred-kilogram level [1] Commitment to Innovation - The company is dedicated to providing high-quality non-natural amino acid products and related technical services to assist in innovative drug research and development [1]